Potential anti-neuroblastoma agents from Juniperus oblonga
- PMID: 31255282
- PMCID: PMC6814253
- DOI: 10.1016/j.bbrc.2019.06.123
Potential anti-neuroblastoma agents from Juniperus oblonga
Abstract
Neuroblastoma (NB) is a neuroendocrine tumor derived from neural crest cells. Approximately 90% of cases occur in children less than 5 years old. The amplification of MYCN correlates with high-risk neuroblastoma and patients with MYCN amplified showed poorer prognosis than those without MYCN amplification. In this study, three compounds isolated from Juniperus oblonga showed anti-proliferative activity against NB cell lines with and without tetracycline inducible MYCN over-expression which were identified as (-)-deoxypodophyllotoxin (1), (-)-matairesinol (2) and (+)-isocupressic acid (3). The effects of compounds 2 and 3 in NB cells included a decrease in NB cell viability and induction of apoptosis. Compound 1 was more effective in NB cells over-expressing MycN. Compound 1 also showed almost 2-fold induction of intracellular free calcium levels in M2(+) cells, which may indicate a different mechanism of action for this compound. Cytotoxicity studies against the human embryonic kidney cell (HEK-293) showed compounds 1, 2 and 3 were ineffective in the non-cancer cells at concentrations approximating their IC50 against the NB cell lines. These results may lead to safer and more effective treatment options for NB patients especially for those with high-risk NB.
Keywords: Apoptosis; Calcium signaling; Juniperus oblonga; MYCN2 amplification; Neuroblastoma.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures




References
-
- Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, Mcgrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Chromosome 1p and 11q deletions and outcome in neuroblastoma, N. Engl. J. Med. 353 (2005) 2243–2253. - PubMed
-
- Brodeur GM, Nakagawara A, Molecular basis of clinical heterogeneity in neuroblastoma, Am. J. Pediatr. Hematol. Oncol. 14 (1992) 111–116. - PubMed
-
- Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage, Science 224 (1984) 1121–1124. - PubMed
-
- Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J, Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour, Nature 305 (1983) 245–248. - PubMed
-
- Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report, J. Clin. Oncol. 27(2009) 289–297. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous